YY2201 tablets
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for YY2201 tablets, covering 2025-05-16 to 2025-05-16. Get the full timeline:
Most recent: Clinical Trial Update: Study on the Safe Dosage and Therapeutic Effect of the Drug YY2201 Tablets on Patients With Advanced Cancer [EARLY_Phase 1]